#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Metastatic gastric cancer Cardiac arrest Trigeminal neuralgia Neuromyelitis optica spectrum disorder Immunodeficiency common variable Exudative retinopathy Hidradenitis Hereditary optic atrophy Shprintzen-Goldberg syndrome Ocular lymphoma B-cell small lymphocytic lymphoma Chordoma Chronic myelomonocytic leukaemia Hypersomnia Hepatitis B More trials…

    Learn about Rare Diseases

    Osteosarcoma recurrent – Treatment Pelizaeus-Merzbacher disease – Basic Information Inclusion body myositis – Treatment Hereditary angioedema – Life with Disease Lymphangiosarcoma – Diagnostics Alagille syndrome – Treatment Lymphangioma – Trials in Disease Paroxysmal nocturnal haemoglobinuria – Life with Disease Synovial sarcoma Glomerulonephritis membranoproliferative – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    OBI-821 Cefalexin Monohydrate Casimersen Clemastine Tx200-Tr101 Glycopyrronium Bromide Sulfasalazine Rbl027.2 Clenbuterol Hydrochloride Valganciclovir Hydrochloride Tulisokibart Ramucirumab Erlotinib Taurine Bi-1910 Formoterol Fumarate Dihydrate Atomoxetine Hydrochloride TUB-030 Masofaniten Fluorometholone More therapies…

    Learn about Your Condition

    Chronic lymphocytic leukaemia Myocarditis Osteosarcoma metastatic Amyloidosis Post-acute COVID-19 syndrome Apheresis Low cardiac output syndrome Glomerulonephritis acute Meniscus operation Hand dermatitis Osteopenia Head injury Bacterial infection Anal abscess Eosinophilic oesophagitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Ganaxolone for Patients with Refractory Status Epilepticus

    Not recruiting

    3 1
    Investigated Diseases:
    • Status epilepticus
    Investigated Drugs:
    • Ganaxolone
    Austria Belgium Croatia Czechia Denmark Finland +8

  • Study on the Effects of Leriglitazone for Adult Men with Cerebral Adrenoleukodystrophy

    Not recruiting

    3 1
    Investigated Diseases:
    • Adrenoleukodystrophy
    Investigated Drugs:
    • Leriglitazone
    France Germany Spain

  • Study on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes

    Not recruiting

    2 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Maridebart Cafraglutide
    Austria Greece Hungary Italy Poland Romania +2

  • Study on the Safety and Effectiveness of ALKS 2680 for Patients with Narcolepsy Type 1

    Not recruiting

    2 1
    Investigated Diseases:
    • Narcolepsy
    Investigated Drugs:
    • Alks 2680
    Belgium Czechia France Italy The Netherlands Spain

  • Study on the Effectiveness and Safety of Remibrutinib for Teens with Chronic Spontaneous Urticaria Not Controlled by H1-Antihistamines

    3 1 1
    Investigated Diseases:
    • Chronic spontaneous urticaria
    Investigated Drugs:
    • Corticosteroids For Systemic Use, Plain
    • Remibrutinib
    Germany Italy The Netherlands Poland Spain
Previous Page
1 … 1,647 1,648 1,649

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!